The Preeclampsia Registry brings together preeclampsia patients, family members, and researchers to find answers to better prevent, treat, and one day, cure preeclampsia.
It's easy to participate from the comfort of your home!
The Preeclampsia Registry is steadfast in our resolve to reach underrepresented audiences and ensure that our Registry reflects the population of women that experience preeclampsia.
The people who volunteer for research studies are vital in preventing, detecting, and treating diseases like preeclampsia. A diverse research participation group ensures we understand how a particular treatment, prevention, or condition affects different kinds of people and nobody is left behind as advances are made.
Learn more about how everyone can play a role to find a cause and a cure:
The registry is a "living database" which means that it continues to grow and evolve as more patients participate and new research studies are launched. By returning to the Registry once a year to provide a health update, you are helping researchers to better understand the impact of preeclampsia several years after pregnancy. Here's a few ways you can jump in now!
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
The Preeclampsia Foundation's published research results.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
May 19, 2023 – NEW YORK – Thermo Fisher Scientific announced on Friday, May 19 that it has obtained clearance from the US Food and Drug Administration for two assays to assess risk of...
A new research study published out of the UK in April 2023 in Hypertension found that more than half of all preeclampsia cases which occur during weeks 37-42 of pregnancy (“at-term”) may b...
Long-term neurodevelopmental follow-up of children exposed to pravastatin in utero If given in early pregnancy pravastatin, (a drug used to lower cholesterol) may decrease the risk of developing pree...
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy (a rat model) Currently the only treatment for preeclampsia starts with delivery of the baby and the placenta....
The nuMom2b study – short for “Nulliparous* Pregnancy Outcomes Study: Monitoring Mothers-To-Be” – is a prospective study that enrolled over 10,000 first time pregnant women acr...